STARCEMENT.BO(STARCEMENT.BO)
STARCEMENT.BO
No analyst ratings available
No analyst price targets available for STARCEMENT.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $41.82B | $46.31B | $54.91B |
| Low | $40.11B | $43.58B | $52.15B |
| High | $44.76B | $51.92B | $60.24B |
| EBITDA Avg | $8.47B | $9.38B | $11.12B |
| Low | $8.13B | $8.83B | $10.56B |
| High | $9.07B | $10.52B | $12.20B |
| EBIT Avg | $5.46B | $6.04B | $7.16B |
| Low | $5.23B | $5.69B | $6.80B |
| High | $5.84B | $6.77B | $7.86B |
| Net Income Avg | $4.15B | $4.55B | $5.05B |
| Low | $3.60B | $3.76B | $4.72B |
| High | $4.58B | $5.00B | $5.69B |
| EPS Avg | $10.28 | $11.25 | $12.50 |
| Low | $8.89 | $9.30 | $11.68 |
| High | $11.32 | $12.37 | $14.08 |
| Analysts (Rev / EPS) | 13 / 12 | 13 / 12 | 8 / 9 |